Securities Analysts Rank Shionogi No. 1 among Drug Markers for “Excellence in Disclosure”

October 17, 2017
The Securities Analysts Association of Japan (SAAJ) has announced that it has ranked Shionogi as No. 1 in the pharmaceuticals division this fiscal year for “excellence in disclosure.” In order to promote disclosure by companies, SAAJ evaluates excellence in information...read more